Physica TT Tibial Plate Follow up Study

March 22, 2024 updated by: Limacorporate S.p.a

A Post Market Clinical Study Evaluating Clinical and Radiographic Outcomes of Total Knee Arthroplasty With Physica Porous KR or Physica Porous PS in Combination With Physica TT Tibial Plate in Cementless Configuration.

This clinical study aims at evaluating clinical, radiographic, patient-reported outcomes of total knee arthroplasty with Physica TT Tibial Plate in combination with Physica Porous KR or Physica Porous PS up to 2 years after surgery, in order to assess the performance of the devices. Furthermore, ithe objective is to collect short-term survivorship of the implant and the incidence of early complications.

Study Overview

Study Type

Observational

Enrollment (Estimated)

130

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Messina, Italy, 98100
        • Casa di Cura Carmona
        • Contact:
          • Marcello La Bruna
        • Principal Investigator:
          • Marcello La Bruna
      • Perugia, Italy, 06100
        • Istituto Clinico Porta Sole
    • Lucca
      • Forte Dei Marmi, Lucca, Italy, 55042
        • Casa di Cura San Camillo Hopital
        • Contact:
          • Alessandro Tripodo
        • Principal Investigator:
          • Alessandro Tripodo
    • Rimini
      • Torre Pedrera, Rimini, Italy, 47922
        • Ospedale Privato Accreditato Sol et Salus
        • Contact:
          • Marco Fravisini
        • Principal Investigator:
          • Marco Fravisini

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

General population of subjects requiring a primary TKR with a diagnosis of painful primary or secondary osteoartrithis not responding to other conservative treatments, after the review of medical history and the radiographic evaluation of the affected knee.

Description

Inclusion Criteria:

  1. Male or female of any race requiring a total knee replacement (TKR) and suitable for receiving Physica Porous KR or Physica Porous PS femoral component in combination with Physica TT Tibial Plate.
  2. Age ≥ 18 years old.
  3. Candidate for primary total knee replacement when clinical indications based on physical examination and medical history include one or more of the following conditions:

    1. Non-inflammatory degenerative joint disease like knee osteoarthritis, post traumatic knee arthritis
    2. Inflammatory degenerative joint disease like rheumatoid arthritis
    3. Any other medical reason for which the investigator deems the subject as a possible candidate for total knee replacement.
  4. Patient has well-preserved and well-functioning collateral ligaments and one of the following conditions:

    1. Absent or not-functioning posterior cruciate ligament and severe antero-posterior instability of the knee joint (for Physica Porous PS)
    2. Undamaged and functional posterior cruciate ligament (for Physica Porous KR)
  5. Patient is able to understand the conditions of the study, to comply with the prescribed rehabilitation as well as willing to perform all scheduled follow-up visits.
  6. Patient signed the study-specific informed consent form approved by the ethics committee before study activities

Exclusion Criteria:

  1. Severe instability of the knee joint secondary to the absence of collateral ligament integrity and/or function. Only for Physica Porous KR: important joint instability and deficiency of posterior cruciate ligament.
  2. Any active or suspected infection (local or systemic) or previous history of infection that may affect the prosthetic joint.
  3. Previous partial knee replacement (unicompartmental, bicompartmental or patellofemoral joint replacement), patellectomy, high tibial osteotomy.
  4. Significant bone loss on femoral or tibial joint side.
  5. Affected by malignant cancer with life expectancy less than 2 years or where cancer treatment might affect the normal postoperative course.
  6. Known incompatibility or allergy to the product materials, and/or metal hypersensitivity to implant materials.
  7. Septicaemia.
  8. Persistent acute or chronic osteomyelitis.
  9. Open epiphyses (immature patient with active bone growth).
  10. Necrotic bone
  11. Arterial vascular insufficiency or nerve diseases of the lower limbs severe enough to interfere with the study evaluation.
  12. Compromised bone stock due to disease, infection or prior implantation that cannot provide adequate support and/or fixation to the prosthesis.
  13. Systemic or metabolic disorders leading to progressive bone deterioration, which may impair fixation and stability of the implant.
  14. Any concomitant disease and dependency that might affect the performance of the implanted prosthesis.
  15. Any clinically major pathology based on clinical medical history or any medical intervention or reason that the Investigator feels may affect the study evaluation.
  16. Neurological or musculoskeletal disorder or disease that may adversely affect gait, functional recovery and evaluation.
  17. Neuromuscular or neurosensory deficit that would hamper the performance assessment of the device.
  18. Any psychiatric illness that would prevent comprehension of the details and nature of the study.
  19. Simultaneously taking part in another surgical intervention study or pain management study that may affect with clinical study outcomes.
  20. Female patient who is pregnant, nursing, or planning a pregnancy.
  21. Important osteoporosis, haemophilic disease.
  22. Internistic problems with high risk for surgery.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Physica Porous KR femoral component

Devices: Physica TT Tibial Plate and Physica Porous KR femoral component

Total knee arthroplasty with Physica TT Tibial Plate and Physica Porous KR femoral component

Devices: Physica TT Tibial Plate and Physica Porous KR femoral component

Data collection of population that underwent total knee arthroplasty with Physica TT Tibial Plate and Physica Porous KR femoral component

Physica Porous PS femoral component

Devices: Physica TT Tibial Plate and Physica Porous PS femoral component

Total knee arthroplasty with Physica TT Tibial Plate and physica Porous PS femoral component

Devices: Physica TT Tibial Plate and Physica Porous KR femoral component

Data collection of population that underwent total knee arthroplasty with Physica TT Tibial Plate and Physica Porous PS femoral component

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of Knee Society Score (KSS) equal or greater than "Good" (score ≥ 70) 2 years after surgery
Time Frame: 2 years after surgery
0-100 scale. Scores rating from 80 to 100 are considered excellent, between 70 and 79 good, between 60 and 69 fair, and less than 60 poor
2 years after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Range of Motion over time up to 2 years after surgery
Time Frame: From preoperative to 2 years after surgery
From preoperative to 2 years after surgery
Changes in Oxford Knee Score (OKS) over time up to 2 years after surgery.
Time Frame: From preoperative to 2 years after surgery
Overall score from 0 to 48, with 48 being the best outcome
From preoperative to 2 years after surgery
Changes in Forgotten Joint Score (FJS) over time up to 2 years after surgery.
Time Frame: From preoperative to 2 years after surgery
Overall score from 0 to 100, with 100 being the best outcome
From preoperative to 2 years after surgery
Changes in Visual Analogue Scale (VAS) Pain over time up to 2 years after surgery.
Time Frame: From preoperative to 2 years after surgery
100 mm line, with 0 mm being best outcome (no pain) and 100 mm worst outcome (very severe pain)
From preoperative to 2 years after surgery
Radiographic implant evaluation and stability assessment from postoperative (baseline) over time up to 2 years after surgery
Time Frame: From preoperative to 2 years after surgery

The treated knee is analyzed postoperatively based on anteroposterior and lateral x-rays view of the knee. The following parametner are evaluated:

  • Presence of radiolucent lines
  • Presence of osteolysis
  • Presence of loosening
  • Presence of heterotopic ossification
  • Presence of periprosthetic fractures
From preoperative to 2 years after surgery
Survival rate (Kaplan-Meier) at 2 years after surgery
Time Frame: From preoperative to 2 years after surgery
From preoperative to 2 years after surgery
Incidence, type and severity of Adverse Device Effects (ADE) and Serious Adverse Device Effects (SADE) up to 2 years follow up
Time Frame: From preoperative to 2 years after surgery
From preoperative to 2 years after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alessandro Tripodo, Casa di Cura San Camillo Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2024

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Study Registration Dates

First Submitted

March 15, 2024

First Submitted That Met QC Criteria

March 22, 2024

First Posted (Actual)

March 29, 2024

Study Record Updates

Last Update Posted (Actual)

March 29, 2024

Last Update Submitted That Met QC Criteria

March 22, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • K-38

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Arthropathy

3
Subscribe